Purchase Order 75F40121P00161
Award Date
4/20/21
Potential Completion Date
9/24/26
Potential Value
$417K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20857, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an ILLUMINA NEXTSEQ2000 SEQUENCING SYSTEM. The contract has a ceiling value of $576,928.00 and a completion date of July 20, 2026. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal contract and subcontract awards from agencies such as the National Institutes of Health (NIH), Centers for...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for NEXTSEQ 500 comprehensive plan service maintenance for two NextSeq 500 sequencing systems at the FDA's location in Berwyn Heights, Maryland. The contract has a ceiling value of $265,801.32 and a period of performance through September 30, 2021. This contract does not have a...
This is a $142,142.04 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an annual maintenance agreement on Illumina's NextSeq2000 genetic sequencing instruments. The contract has a period of performance of 5 years, from June 6, 2024 to June 6, 2029. Illumina is a manufacturer of genetic sequencing systems, reagents, and bioinformatics solutions, and has provided these types of products and services to federal agencies such as the National...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of a "HIGH-THROUGHPUT DESKTOP SEQUENCER WITH DATA ANALYSIS SYSTEM" and has a ceiling value of $426,000.30. There is no set-aside designation for this contract. Illumina has previously provided a range of sequencing systems, reagents, and...
This firm fixed price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, to provide one Illumina NextSeq 2000 Sequencer along with post-warranty correction and remedial repair services. The contract has a ceiling value of $534,536 and a performance period through December 11, 2028. There is no set-aside designation for this procurement. The contract was awarded in response to a...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a NextSeq 500 Sequencing System, with a ceiling value of $292,000.00 and a completion date of September 23, 2016. The contract does not have a set-aside designation. Illumina has previously been awarded prime federal contracts and subcontracts by various...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of NextSeq 500 High Output Kits, with a ceiling value of $193,380.44 and a completion date of February 17, 2019. This delivery order appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery,...
This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an ILLUMINA NOVASEQ 6000 SERVICE CONTRACT. The contract has a period of performance through September 26, 2029 and a ceiling value of $780,844.00. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that have been used to support research and diagnostic efforts across federal agencies such as the NIH, CDC, USDA, and VA. This contract...